Both in Pharmaceuticals
Savara vs Janux Therapeutics
Over the past year SVRA returned +44.3% and JANX returned −28.5%; their daily moves had a correlation of 0.22.
SVRA +44.3% JANX −28.5%Growth of $1, one year, split-adjusted
| Metric | SVRA | JANX |
|---|---|---|
| Price | $5.08 | $16.95 |
| Market cap | $1.04B | $1.04B |
| Today | +0.20% | +2.23% |
| 1 month | −3.4% | −6.0% |
| 6 months | +0.6% | +30.1% |
| Year to date | −15.8% | +22.8% |
| 1 year | +44.3% | −27.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −214.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 43.2× |
| Net cash | $142.9M | $970.9M |
| Dividend yield | — | — |
| Volatility (60d) | 44.0% | 46.4% |
| Short % of float | 30.2% | 13.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).